The Prostatype Genomics share
Prostatype Genomics AB has issued shares in one series. The company’s share is as of 27 October 2020 listed on NASDAQ First North Growth Market under the ticker PROGEN and is, as from 31 October 2024, traded with ISIN code SE0023261532.
https://www.nasdaqomxnordic.com/aktier/microsite?Instrument=SSE207035
All shares hold equal rights to the company’s assets and profits. The company’s share is denominated in SEK and has been issued in accordance with Swedish law. The shares give preferential rights to future issues unless otherwise decided. Each share entails equal rights to dividends and to any surplus in the event of liquidation.
There are no restrictions on any dividend other than those resulting from Swedish law. All shares are freely transferable. The shares are registered in electronic form in accordance with the record reservation in the Articles of association. The share register is kept by Euroclear.
On the Extraordinary General Meeting held on 22 October 2024 a reverse split of the share with 1000:1 and a reduction of the share capital was concluded. Prior to this reverse split the share was traded with ISIN code SE0014684569.
Please note that the historic share price data and trading statistics below may hold adjustments for corporate actions as share issues, share splits, reverse share splits etc and may therefore not tie to actual historic trading prices and trading volumes. Please read this White Paper for detailed information on any adjustment mechanics.